Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,137.90
(
1.05%
)
US TECH 100
26,218.00
(
1.73%
)
Dow Jones
49,490.03
(
0.09%
)
Brent Oil
98.97
(
2.32%
)
Bitcoin
77,735.56
(
-0.64%
)
News Focus
News Focus
Post# of 822494
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

HyGro

Send PM Follow Ignore
Followers 24
Posts 4174
Boards Moderated 0
Alias Born 12/18/2019

HyGro

Re: SkyLimit2022 post# 559440

Saturday, 01/14/2023 9:28:43 PM

Saturday, January 14, 2023 9:28:43 PM

Post# of 822494
But yet it is not when you cheery-pick your sample (complete/near complete resection) and then compare to trials that did not screen for such a high level of health naïve GBM patients.

Dr. Ashcan didn't participate in the statisical analysis that was controlled and directed by Dr. Bosch, an NWBO employee, significant shareholder and had a clear conflict of interest,

Dr. Ashcan wasn't even honest with his UK peers by reporting the PFS results. At least the first TLD data reporting included that data.
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News